1-150497543-A-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_025150.5(TARS2):​c.1034A>G​(p.His345Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00666 in 1,614,066 control chromosomes in the GnomAD database, including 55 homozygotes. In-silico tool predicts a benign outcome for this variant. 17/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. H345H) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0054 ( 6 hom., cov: 32)
Exomes 𝑓: 0.0068 ( 49 hom. )

Consequence

TARS2
NM_025150.5 missense

Scores

1
17

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 0.0130

Publications

9 publications found
Variant links:
Genes affected
TARS2 (HGNC:30740): (threonyl-tRNA synthetase 2, mitochondrial) This gene encodes a member of the class-II aminoacyl-tRNA synthetase family. The encoded protein is a mitochondrial aminoacyl-tRNA synthetase. Alternative splicing results in multiple transcript variants. A related pseudogene has been identified on chromosome 4. [provided by RefSeq, Dec 2012]
TARS2 Gene-Disease associations (from GenCC):
  • combined oxidative phosphorylation defect type 21
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet
  • Leigh syndrome
    Inheritance: AR Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.004318863).
BP6
Variant 1-150497543-A-G is Benign according to our data. Variant chr1-150497543-A-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 380192.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00535 (815/152288) while in subpopulation NFE AF = 0.00723 (492/68014). AF 95% confidence interval is 0.00671. There are 6 homozygotes in GnomAd4. There are 410 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 6 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TARS2NM_025150.5 linkc.1034A>G p.His345Arg missense_variant Exon 10 of 18 ENST00000369064.8 NP_079426.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TARS2ENST00000369064.8 linkc.1034A>G p.His345Arg missense_variant Exon 10 of 18 1 NM_025150.5 ENSP00000358060.3

Frequencies

GnomAD3 genomes
AF:
0.00536
AC:
815
AN:
152170
Hom.:
6
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00116
Gnomad AMI
AF:
0.116
Gnomad AMR
AF:
0.00301
Gnomad ASJ
AF:
0.000576
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00124
Gnomad FIN
AF:
0.0101
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00723
Gnomad OTH
AF:
0.00382
GnomAD2 exomes
AF:
0.00496
AC:
1245
AN:
251124
AF XY:
0.00481
show subpopulations
Gnomad AFR exome
AF:
0.000984
Gnomad AMR exome
AF:
0.00202
Gnomad ASJ exome
AF:
0.000893
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0108
Gnomad NFE exome
AF:
0.00722
Gnomad OTH exome
AF:
0.00619
GnomAD4 exome
AF:
0.00679
AC:
9932
AN:
1461778
Hom.:
49
Cov.:
31
AF XY:
0.00662
AC XY:
4812
AN XY:
727198
show subpopulations
African (AFR)
AF:
0.00105
AC:
35
AN:
33478
American (AMR)
AF:
0.00215
AC:
96
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.000689
AC:
18
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.00197
AC:
170
AN:
86252
European-Finnish (FIN)
AF:
0.0101
AC:
539
AN:
53414
Middle Eastern (MID)
AF:
0.00526
AC:
30
AN:
5702
European-Non Finnish (NFE)
AF:
0.00779
AC:
8663
AN:
1111982
Other (OTH)
AF:
0.00631
AC:
381
AN:
60390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
484
969
1453
1938
2422
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
326
652
978
1304
1630
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00535
AC:
815
AN:
152288
Hom.:
6
Cov.:
32
AF XY:
0.00551
AC XY:
410
AN XY:
74464
show subpopulations
African (AFR)
AF:
0.00115
AC:
48
AN:
41562
American (AMR)
AF:
0.00301
AC:
46
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.000576
AC:
2
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5188
South Asian (SAS)
AF:
0.00124
AC:
6
AN:
4822
European-Finnish (FIN)
AF:
0.0101
AC:
107
AN:
10618
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.00723
AC:
492
AN:
68014
Other (OTH)
AF:
0.00378
AC:
8
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
48
95
143
190
238
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00607
Hom.:
9
Bravo
AF:
0.00531
TwinsUK
AF:
0.0111
AC:
41
ALSPAC
AF:
0.00467
AC:
18
ESP6500AA
AF:
0.000908
AC:
4
ESP6500EA
AF:
0.00884
AC:
76
ExAC
AF:
0.00509
AC:
618
Asia WGS
AF:
0.000577
AC:
2
AN:
3478
EpiCase
AF:
0.00605
EpiControl
AF:
0.00693

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:6
Jun 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

TARS2: BP4, BS2

Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Jun 14, 2017
Mayo Clinic Laboratories, Mayo Clinic
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Aug 01, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Sep 19, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.048
BayesDel_addAF
Benign
-0.62
T
BayesDel_noAF
Benign
-0.65
CADD
Benign
0.75
DANN
Benign
0.25
DEOGEN2
Benign
0.0032
T;.;T;T
Eigen
Benign
-1.4
Eigen_PC
Benign
-1.2
FATHMM_MKL
Benign
0.013
N
LIST_S2
Benign
0.60
T;T;T;T
M_CAP
Benign
0.022
T
MetaRNN
Benign
0.0043
T;T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.0
.;.;N;.
PhyloP100
0.013
PrimateAI
Benign
0.32
T
PROVEAN
Benign
0.0
.;N;N;.
REVEL
Benign
0.0
Sift
Pathogenic
0.0
.;T;T;.
Sift4G
Benign
0.69
T;T;T;T
Vest4
0.19
ClinPred
0.0035
T
GERP RS
0.48
Varity_R
0.018
gMVP
0.53
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.040
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs115390773; hg19: chr1-150470019; API